Author Correction: Development of spirulina for the manufacture and oral delivery of protein therapeutics.

Saved in:
Bibliographic Details
Title: Author Correction: Development of spirulina for the manufacture and oral delivery of protein therapeutics.
Authors: Jester BW; Lumen Bioscience, Seattle, WA, USA., Zhao H; Lumen Bioscience, Seattle, WA, USA., Gewe M; Lumen Bioscience, Seattle, WA, USA., Adame T; Lumen Bioscience, Seattle, WA, USA., Perruzza L; Institute for Research in Biomedicine, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Bellinzona, Switzerland., Bolick DT; Division of Infectious Diseases & International Health, University of Virginia School of Medicine, Charlottesville, VA, USA., Agosti J; Lumen Bioscience, Seattle, WA, USA., Khuong N; Lumen Bioscience, Seattle, WA, USA., Kuestner R; Lumen Bioscience, Seattle, WA, USA., Gamble C; Lumen Bioscience, Seattle, WA, USA., Cruickshank K; Lumen Bioscience, Seattle, WA, USA., Ferrara J; Lumen Bioscience, Seattle, WA, USA., Lim R; Lumen Bioscience, Seattle, WA, USA., Paddock T; Lumen Bioscience, Seattle, WA, USA., Brady C; Lumen Bioscience, Seattle, WA, USA., Ertel S; Lumen Bioscience, Seattle, WA, USA., Zhang M; Lumen Bioscience, Seattle, WA, USA., Pollock A; Lumen Bioscience, Seattle, WA, USA., Lee J; Lumen Bioscience, Seattle, WA, USA., Xiong J; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USA.; Merck & Co., West Point, PA, USA., Tasch M; Lumen Bioscience, Seattle, WA, USA., Saveria T; Lumen Bioscience, Seattle, WA, USA., Doughty D; Lumen Bioscience, Seattle, WA, USA., Marshall J; Lumen Bioscience, Seattle, WA, USA., Carrieri D; Lumen Bioscience, Seattle, WA, USA.; Sandia National Laboratories, Livermore, CA, USA., Goetsch L; Lumen Bioscience, Seattle, WA, USA., Dang J; Lumen Bioscience, Seattle, WA, USA., Sanjaya N; Lumen Bioscience, Seattle, WA, USA., Fletcher D; Lumen Bioscience, Seattle, WA, USA., Martinez A; Lumen Bioscience, Seattle, WA, USA., Kadis B; Lumen Bioscience, Seattle, WA, USA., Sigmar K; Lumen Bioscience, Seattle, WA, USA., Afreen E; Lumen Bioscience, Seattle, WA, USA., Nguyen T; Lumen Bioscience, Seattle, WA, USA., Randolph A; Lumen Bioscience, Seattle, WA, USA., Taber A; Lumen Bioscience, Seattle, WA, USA., Krzeszowski A; Lumen Bioscience, Seattle, WA, USA., Robinett B; Lumen Bioscience, Seattle, WA, USA., Volkin DB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USA., Grassi F; Institute for Research in Biomedicine, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Bellinzona, Switzerland., Guerrant R; Division of Infectious Diseases & International Health, University of Virginia School of Medicine, Charlottesville, VA, USA., Takeuchi R; Lumen Bioscience, Seattle, WA, USA.; TScan Therapeutics, Waltham, MA, USA., Finrow B; Lumen Bioscience, Seattle, WA, USA., Behnke C; Lumen Bioscience, Seattle, WA, USA., Roberts J; Lumen Bioscience, Seattle, WA, USA. jroberts@lumen.bio.
Source: Nature biotechnology [Nat Biotechnol] 2022 Jun; Vol. 40 (6), pp. 974.
Publication Type: Published Erratum
Journal Info: Publisher: Nature America Publishing Country of Publication: United States NLM ID: 9604648 Publication Model: Print Cited Medium: Internet ISSN: 1546-1696 (Electronic) Linking ISSN: 10870156 NLM ISO Abbreviation: Nat Biotechnol Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1546-1696
DOI:10.1038/s41587-022-01323-0